Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (HTSUF)
:HTSUF
Total Valuation
Hisamitsu Pharmaceutical Co has a market cap or net worth of $2.27B. The enterprise value is ―.
Market Cap$2.27B
Enterprise Value―
Share Statistics
Hisamitsu Pharmaceutical Co has 85,164,894 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding85,164,894
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hisamitsu Pharmaceutical Co’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.48%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)3.48%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee51.36M
Profits Per Employee5.06M
Employee Count2,759
Asset Turnover0.43
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Hisamitsu Pharmaceutical Co is 21.33. Hisamitsu Pharmaceutical Co’s PEG ratio is 2.76.
PE Ratio21.33
PS Ratio0.00
PB Ratio1.15
Price to Fair Value1.12
Price to FCF-334.48
Price to Operating Cash Flow72.70
PEG Ratio2.76
Income Statement
In the last 12 months, Hisamitsu Pharmaceutical Co had revenue of 141.71B and earned 13.97B in profits. Earnings per share was 181.61.
Revenue141.71B
Gross Profit78.97B
Operating Income13.17B
Pretax Income19.19B
Net Income13.97B
EBITDA24.37B
Earnings Per Share (EPS)181.61
Cash Flow
In the last 12 months, operating cash flow was 4.13B and capital expenditures -5.02B, giving a free cash flow of -892.50M billion.
Operating Cash Flow4.13B
Free Cash Flow-892.50M
Free Cash Flow per Share-10.48
Dividends & Yields
Hisamitsu Pharmaceutical Co pays an annual dividend of $0.298, resulting in a dividend yield of 1.81%
Dividend Per Share$0.298
Dividend Yield1.81%
Payout Ratio25.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.23
52-Week Price Change41.79%
50-Day Moving Average30.17
200-Day Moving Average28.27
Relative Strength Index (RSI)67.68
Average Volume (3m)3.00
Important Dates
Hisamitsu Pharmaceutical Co upcoming earnings date is Jul 10, 2025, TBA Not Confirmed.
Last Earnings DateJan 9, 2025
Next Earnings DateJul 10, 2025
Ex-Dividend DateFeb 27, 2025
Financial Position
Hisamitsu Pharmaceutical Co as a current ratio of 4.22, with Debt / Equity ratio of 1.13%
Current Ratio4.22
Quick Ratio3.76
Debt to Market Cap<0.01
Net Debt to EBITDA-4.53
Interest Coverage Ratio731.50
Taxes
In the past 12 months, Hisamitsu Pharmaceutical Co has paid 4.75B in taxes.
Income Tax4.75B
Effective Tax Rate0.25
Enterprise Valuation
Hisamitsu Pharmaceutical Co EV to EBITDA ratio is 7.70, with an EV/FCF ratio of 36.42.
EV to Sales1.32
EV to EBITDA7.70
EV to Free Cash Flow36.42
EV to Operating Cash Flow10.32
Balance Sheet
Hisamitsu Pharmaceutical Co has $116.64B in cash and marketable securities with ¥2.93B in debt, giving a net cash position of -$113.71B billion.
Cash & Marketable Securities$116.64B
Total Debt¥2.93B
Net Cash-$113.71B
Net Cash Per Share-$1.34K
Tangible Book Value Per Share$3.38K
Margins
Gross margin is 57.79%, with operating margin of 9.29%, and net profit margin of 9.86%.
Gross Margin57.79%
Operating Margin9.29%
Pretax Margin13.54%
Net Profit Margin9.86%
EBITDA Margin17.20%
EBIT Margin13.55%
Analyst Forecast
The average price target for Hisamitsu Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―